Immune-Mediated Liver Disease Special Interest Group
Immune-Mediated Liver Disease Special Interest Group
The Immune-Mediated Liver Disease Special Interest Group (SIG) is an affiliate of the British Association for Study of Liver Disease (BASL) and cross cuts existing programmes of activity as part of UK-PSC, UK-PBC, UK-AIH and IgG4-related hepatobiliary disease. The remit of this programme will be to generate high quality multi-centre observational cohort studies, increase patient registration to each of the core UK-autoimmune liver disease strands, and perhaps most importantly, develop collaborative grant applications on a larger scale, focussing on key areas of research priority set out by patients, clinicians and industry. If anyone wishes to join the group please contact the BASL secretariat on Samantha@basl.org.uk.
Steering Committee
Dr Palak Trivedi (Chair), University Hospitals Birmingham
Dr Richard Aspinall, Queen Alexandra Hospital, Portsmouth
Dr Emma Culver, Royal Free Hospital, London
Dr Jessica Dyson, Freeman Hospital, Newcastle Upon Tyne
Professor Michael Heneghan, King's College Hospital, London
Professor David Jones, Newcastle University
Dr George Mells, Addenbrooke's Hospital, Cambridge
Dr Douglas Thorburn, Royal Free Hospital, London
Dr Andrew Yeoman, Royal Gwent Hospital
Patient representatives:
Ann Brownlee, AIH Support
Robert Mitchell-Thain, PBC Foundation
Martine Walmsley, PSC Support
Resources
To be added following the first SIG meeting.
